Lost therapeutic potential of monocyte-derived dendritic cells through lost tissue homing: Stable restoration of gut specificity with retinoic acid

Clinical and Experimental Immunology

Volumn 174, Issue 1, 2013, Pages 109-119

  Bernardo, D ^a   Mann, E R ^a   Al Hassi, H O ^a   English, N R ^a   Man, R ^b   Lee, G H ^a,b   Ronde, E ^a   Landy, J ^a,b   Peake, S T C ^a,b   Hart, A L ^a,b   Knight, S C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

Author keywords

Dendritic cell; Homing markers; Immunotherapy; Retinoic acid; Ulcerative colitis

Indexed keywords

BETA7 INTEGRIN; CD14 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; HLA DR ANTIGEN; RETINOIC ACID;

ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL HOMING; CELL MATURATION; COLON; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; IN VITRO STUDY; INTESTINE; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; ULCERATIVE COLITIS;

DENDRITIC CELL; HOMING MARKERS; IMMUNOTHERAPY; RETINOIC ACID; ULCERATIVE COLITIS;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; COLITIS, ULCERATIVE; DENDRITIC CELLS; FEMALE; GASTROINTESTINAL TRACT; HUMANS; MALE; MONOCYTES; ORGAN SPECIFICITY; RECEPTORS, CCR; RECEPTORS, CCR7; TRETINOIN;

EID: 84883609808     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12118     Document Type: Article

References (36)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-252.
2. Niess JH, Reinecker HC. Dendritic cells: the commanders-in-chief of mucosal immune defenses. Curr Opin Gastroenterol 2006; 22:354-360.
3. Collin M, Bigley V, Haniffa M, Hambleton S. Human dendritic cell deficiency: the missing ID? Nat Rev Immunol 2011; 11:575-583.
4. Figdor CG, de Vries IJ, Lesterhuis WJ etal. Dendritic cell immunotherapy: mapping the way. Nat Med 2004; 5:475-480.
5. García F, Routy JP. Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1. Vaccine 2011; 29:6454-6463.
6. Steinman RM. Dendritic cells in vivo: a key target for a new vaccine science. Immunity 2008; 29:319-324.
7. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007; 7:610-621.
8. Ricart E, Panés J, Benítez-Ribas D. Dendritic cells: a new horizon in cell therapy for inflammatory bowel disease?. Gastroenterol Hepatol 2011; 34:100-106.
9. Yamanishi H, Murakami H, Ikeda Y etal. Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4(+)CD25(-) T cells. J Immunol 2012; 188:2164-2172.
10. Gonzalez-Rey E, Delgado M. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide. Gastroenterology 2006; 131:1799-1811.
11. Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol 2002; 32:1445-1454.
12. Mora JR, Bono MR, Manjunath N etal. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 2003; 424:88-93.
13. Johansson-Lindbom B, Svensson M, Wurbel MA etal. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med 2003; 198:963-969.
14. Mora JR, Iwata M, Eksteen B etal. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006; 314:1157-1160.
15. van den Bogaerde J, Kamm MA, Knight SC. Immune sensitization to food, yeast and bacteria in Crohn's disease. Aliment Pharmacol Ther 2001; 15:1647-1653.
16. Mann ER, Bernardo D, Al-Hassi HO etal. In humans, gut-specific homeostatic dendritic cells are generated from blood precursors by the gut microenvironment. Inflamm Bowel Dis 2012; 18:1275-1286.
17. Rimoldi M, Chieppa M, Salucci V etal. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005; 6:507-514.
18. Butler M, Ng CY, van Heel DA etal. Modulation of dendritic cell phenotype and function in an in vitro model of the intestinal epithelium. Eur J Immunol 2006; 36:864-874.
19. Iliev ID, Mileti E, Matteoli G etal. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol 2009; 2:340-350.
20. Iliev ID, Spadoni I, Mileti E etal. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 2009; 58:1481-1489.
21. Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV etal. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007; 204:1757-1764.
22. Mora JR, Iwata M, Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8:685-698.
23. Iwata M, Hirakiyama A, Eshima Y etal. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004; 21:527-538.
24. Bagwell CB. Hyperlog-a flexible log-like transform for negative, zero, and positive valued data. Cytometry A 2005; 64:34-42.
25. Dudda JC, Lembo A, Bachtanian E etal. Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor patterns of T cells: important roles for soluble factors and tissue microenvironments. Eur J Immunol 2005; 35:1056-1065.
26. Laffont S, Siddiqui KR, Powrie F. Intestinal inflammation abrogates the tolerogenic properties of MLN CD103+ dendritic cells. Eur J Immunol 2010; 40:1877-1883.
27. hi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med 2012; 209:139-155.
28. Bernardo D, Vallejo-Diez S, Mann ER etal. IL-6 controls the intestinal inflammation in human ulcerative colitis and mediates the conditioning of dendritic cells towards a pro-inflammatory phenotype with increased skin-homing phenotype and skin-imprinting capacity on T-cells. Eur J Immunol 2012; 42:1337-1353.
29. Karlsen M, Hovden AO, Vogelsang P etal. Bromelain treatment leads to maturation of monocyte-derived dendritic cells but cannot replace PGE2 in a cocktail of IL-1β, IL-6, TNF-α and PGE2. Scand J Immunol 2011; 74:135-143.
30. DePaolo RW, Abadie V, Tang F etal. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 2011; 471:220-224.
31. Gibbons DL, Spencer J. Mouse and human intestinal immunity: same ballpark, different players; different rules, same score. Mucosal Immunol 2011; 4:148-157.
32. von Boehmer H. Oral tolerance: is it all retinoic acid? J Exp Med 2007; 204:1737-1739.
33. Hammerschmidt SI, Friedrichsen M, Boelter J etal. Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice. J Clin Invest 2011; 121:3051-3061.
34. Bedford PA, Knight SC. The effect of retinoids on dendritic cell function. Clin Exp Immunol 1989; 75:481-486.
35. Feng T, Cong Y, Qin H etal. Generation of mucosal dendritic cells from bone marrow reveals a critical role of retinoic acid. J Immunol 2010; 185:5915-5925.
36. Bernardo D, Al-Hassi HO, Mann ER etal. T-cell proliferation and forkhead box P3 expression in human T cells are dependent on T-cell density: physics of a confined space? Hum Immunol 2012; 73:223-231.